Celldex to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Celldex Therapeutics (NASDAQ:CLDX) will participate in several virtual investor conferences in November 2021. Notable events include the Guggenheim 3rd Annual Healthcare Talks Neuro/Immunology Conference on November 16 at 10:20 a.m. ET, the Jefferies London Healthcare Conference available on-demand starting November 18 at 3:00 a.m. ET, and the Evercore ISI 4th Annual HealthCONx Conference on November 30 at 8:25 a.m. ET. Webcasts of these presentations will be accessible on the Celldex website for 30 days post-event.

News Market Reaction – CLDX

-2.87%

-2.87% Session move

In the trading session that priced this news, CLDX declined 2.87%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HAMPTON, N.J., Nov. 11, 2021 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that management will participate in fireside chats at the following virtual investor conferences in November:

• Guggenheim 3^rd Annual Healthcare Talks Neuro/Immunology Conference on Tuesday, November 16, 2021 at 10:20 a.m. ET
• Jefferies London Healthcare Conference available on-demand beginning Thursday, November 18, 2021 at 3:00 a.m. ET / 8:00 a.m. GMT
• Evercore ISI 4^th Annual HealthCONx Conference on Tuesday, November 30, 2021 at 8:25 a.m. ET
  

Webcasts of the presentations will be available on the "Events & Presentations" page of the "Investors & Media" section of the Celldex website. Replays will be available for 30 days following the events.

About Celldex Therapeutics, Inc.
Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that address devastating diseases for which available treatments are inadequate. Our pipeline includes antibody-based therapeutics which have the ability to engage the human immune system and/or directly affect critical pathways to improve the lives of patients with inflammatory diseases and many forms of cancer. Visit www.celldex.com.

Company Contact
Sarah Cavanaugh
Senior Vice President, Corporate Affairs & Administration
(508) 864-8337
scavanaugh@celldex.com

Patrick Till
Senior Director, Investor Relations & Corporate Communications
(484) 788-8560
ptill@celldex.com

FAQ

When is Celldex participating in the Guggenheim Conference?

Celldex will present at the Guggenheim 3rd Annual Healthcare Talks Neuro/Immunology Conference on November 16, 2021, at 10:20 a.m. ET.

What are the dates for Celldex's upcoming investor conferences?

Celldex will be at the Jefferies London Healthcare Conference on November 18, 2021, and the Evercore ISI 4th Annual HealthCONx Conference on November 30, 2021.

How can I access the webcasts of Celldex's presentations?

Webcasts of Celldex's presentations will be available on their 'Events & Presentations' page for 30 days after each event.

What time will Celldex's presentation be available during the Jefferies London Conference?

The Jefferies London Healthcare Conference presentation will be available on-demand starting November 18, 2021, at 3:00 a.m. ET / 8:00 a.m. GMT.